Here we show that TNT gains access to the cytosol of Mtb-infected macrophages, where it hydrolyzes the essential coenzyme NAD + . Expression or injection of a noncatalytic TNT mutant showed no cytotoxicity in macrophages or in zebrafish zygotes, respectively, thus demonstrating that the NAD + glycohydrolase activity is required for TNT-induced cell death. To prevent self-poisoning, Mtb produces an immunity factor for TNT (IFT) that binds TNT and inhibits its activity. The crystal structure of the TNT-IFT complex revealed a new NAD + glycohydrolase fold of TNT, the founding member of a toxin family widespread in pathogenic microorganisms. npg
a r t i c l e s Tuberculosis is a highly infectious disease and a global health threat. Survival within macrophages is a key feature of Mtb pathogenesis that is crucial to persistent infection in the human host 1 . The battle between Mtb and the human immune system to control the fate of infected macrophages is critical in determining the outcome of infection 2 . The ability to control the timing and mode of host-cell death has a key role in many microbial infections 3 . Virulent Mtb induces necrosis of infected cells and suppresses host-cell apoptosis to evade immune responses and to disseminate 4, 5 . Killing of infected macrophages by necrosis is dependent on the ESX-1 secretion system and has been attributed to the membrane activity of ESAT-6 (ref. 6) . In contrast, apoptosis of infected macrophages is induced by the host immune system to control bacterial infection. Subsequently, apoptotic bodies containing Mtb are scavenged by other activated macrophages, or are taken up by dendritic cells, to facilitate priming of antigen-specific T cells and stimulation of adaptive immunity 4 . Thus, the fate of infected macrophages profoundly affects host resistance to Mtb 2 .
The molecular mechanisms by which Mtb induces macrophage necrosis are largely unknown 7, 8 . Many bacterial pathogens use toxic proteins to kill host cells 9 . The lack of proteins in Mtb with homology to known bacterial toxins and the failure to isolate secreted proteins with strong toxicity against host cells has led to the widespread belief that Mtb does not encode these classical virulence factors [10] [11] [12] . However, this paradigm was challenged by our discovery that the outer-membrane protein CpnT is the main cytotoxicity factor of Mtb in macrophages 13 . Mtb uses CpnT by secreting its toxic C-terminal domain (residues 651-846), which induces necrotic death in host cells by an unknown mechanism 13 . Hence, we named the secreted C-terminal domain of CpnT 'TNT' .
In this study, we set out to identify the mechanism of TNTinduced necrotic cell death at the functional and structural level. We demonstrate that TNT possesses NAD + glycohydrolase activity, which depletes cellular NAD + pools and results in host-cell death. TNT mutants with lower or abrogated NAD + glycohydrolase activity show decreased or no cytotoxicity in macrophages and zebrafish, respectively, thus establishing a link between the enzymatic activity and toxicity of TNT. We further identify an endogenous protein that acts as an antitoxin for TNT that prevents Mtb from self-poisoning. The crystal structure of TNT in complex with its antitoxin shows a new module for NAD + binding and hydrolysis that is distinct from those of known NAD + -utilizing toxins.
RESULTS

TNT hydrolyzes NAD +
We found that recombinant expression of the gene encoding TNT (here denoted tnt; located at the 3′ end of rv3903c, encoding the secreted C-terminal domain) was toxic in all tested prokaryotic and eukaryotic cells, suggesting a common cellular target. Deep sequencing of Escherichia coli RNA revealed that tnt expression induced nadA and nadB transcription by 16-and 44-fold, respectively ( Supplementary Fig. 1a ). These genes encode key enzymes in NAD + biosynthesis, thus suggesting a link between TNT and NAD + . Indeed, tnt expression completely depleted NAD + in E. coli and Jurkat T cells ( Supplementary Fig. 1b) , a result indicating an involvement of TNT in degradation of cellular NAD + . We found that purified recombinant TNT (Supplementary Fig. 2 ) hydrolyzed NAD + in vitro and was inhibited by a TNT-specific antibody, demonstrating that TNT degrades NAD + (Fig. 1a) . NAD + is an essential coenzyme in many redox reactions as well as a substrate for NAD + -consuming enzymes 14 with important roles in transcriptional regulation and longevity 15 . Depletion of cytosolic NAD + compromises ATP generation by glycolysis and leads to necrotic cell death 16, 17 . Thus, NAD + hydrolysis might explain TNT's cytotoxicity.
All known NAD + -degrading enzymes release nicotinamide and a second reaction product that varies with the specific hydrolytic mechanism. NAD + glycohydrolases and ADP-ribosyl cyclases produce ADP-ribose and cyclic ADP-ribose, respectively, whereas ADP-ribosyltransferases attach ADP-ribose to a specific target protein. Thin-layer chromatography revealed that TNT is a glycohydrolase that efficiently cleaves NAD + into nicotinamide and ADP-ribose in vitro in the absence of any other protein ( Supplementary Fig. 1c) . A kinetic analysis of NAD + hydrolysis by TNT ( Fig. 1b and Supplementary Fig. 3a,b ) yielded a K m of 614 ± 43 µM (mean ± s.d.), which is near the physiological NAD + concentration of ~500-600 µM in human cells 18 , a turnover number (k cat ) of 52 s −1 and a catalytic efficiency (k cat /K m ) of 8.4 × 10 4 M −1 s −1 ( Fig. 1b and Supplementary Table 1 ). That TNT has maximal activity at pH 6.5 but is only marginally active at pH 5.5 ( Supplementary Fig. 3c ) suggests that TNT is not active in phagolysosomes that reach pH values of 5.2 and below 19 . TNT is also remarkably heat stable, retaining approximately 50% of its activity after prolonged heating at 95 °C (Fig. 1c) . The pH dependency and heat stability of TNT match the uncharacterized NAD + glycohydrolase activity identified in Mtb cell extracts half a century ago 20, 21 .
The Mtb protein Rv3902c binds to and inactivates TNT
The only other known bacterial NAD + glycohydrolase is the secreted toxin SPN of Streptococcus pyogenes 22 . S. pyogenes protects itself against the toxicity of SPN by producing the immunity factor IFS, which is encoded in the spn operon and tightly binds to and inactivates SPN 23 . However, SPN and IFS have no sequence similarities to any Mtb protein.
Because tnt expression is toxic in Mtb (data not shown), we reasoned that rv3902c, the last gene in the cpnT operon, might encode an antitoxin to TNT. Indeed, equimolar amounts of purified recombinant Rv3902c protein completely inhibited TNT NAD + glycohydrolase activity (Fig. 1a) . Surface plasmon resonance (SPR) experiments with purified maltose-binding protein (MBP)-tagged TNT and Rv3902c proteins ( Fig. 2a ) revealed that the two proteins form a stable complex with a K d of 2.3 × 10 −10 M (Fig. 2b) . Remarkably, an uncharacterized heat-labile 'inhibitor' of Mtb NAD + glycohydrolase activity was also described in the 1960s 24, 25 . In agreement with that report, our folding studies revealed that a complex of Rv3902c with TNT denatured irreversibly, with an apparent melting temperature of ~65.4 °C, thus leading to large conformational changes of the TNT-IFT complex and liberating TNT ( Fig. 2c and Supplementary Fig. 2c) . These experiments demonstrate that Rv3902c inhibits the NAD + glycohydrolase activity of TNT by complex formation. To our knowledge, this constitutes the first inhibitor of a secreted toxin in Mtb; hence, we named Rv3902c immunity factor for TNT (IFT).
The atomic structure of the TNT-IFT complex
The discovery of IFT enabled us to purify milligram quantities of the TNT-IFT complex from E. coli after coexpression of the corresponding genes (Supplementary Fig. 2) . We crystallized the TNT-IFT complex at physiological pH and determined its structure to an R work /R free of 12.8/14.3%, at 1.1-Å resolution ( Table 1) . The TNT-IFT complex adopts a blocky conformation of 50 × 50 × 35 Å 3 that resembles a 'ball in a hand' (Fig. 3a) . IFT (the 'ball') fills a deep cavity in TNT (the 'hand') that buries ~20% of the complex solvent-accessible area (~3,490 Å 2 ). Consistently with the picomolar K d measured by SPR, the extensive binding interface between TNT and IFT involves approximately one-third of the residues in each protein and results in over 50, mainly electrostatic, contacts. Strikingly, both TNT and IFT have minimal internal hydrophobic cores, and as much as 97% of their residues are exposed on the structure surface, thus resulting in very large predicted solvation energies (∆G f of −157 and −163 kcal/mol for TNT and IFT, respectively).
The TNT structure consists of two regions: a 'thumb' (residues 648-719) and a 'palm' domain (residues 720-846) ( Fig. 3b) . Threequarters of the residues in the thumb domain adopt a random-coiled conformation interrupted by two short α-helices (α 1 and α 2 ) and two Table 1 ) revealed subtle structural differences between residues 669-679, possibly caused by the lack of crystal contacts in this region and underscoring the structural plasticity of this domain. The thumb wraps around the palm domain, which is formed by a six-stranded β-sheet surrounded by two short α-helices and two 3 10 helices. Four strands, arranged into two nearly orthogonal antiparallel β-hairpins (β 4 -β 6 ; β 7 and β 8 ), are substantially longer and resemble the four fingers of a hand ( Fig. 3b ). IFT adopts a globular structure that consists of a β-rich domain containing two antiparallel β-sheets (β 1 -β 5 and β 7 -β 9 ) and a helical domain, exposed on the opposite surface, formed by four α-helices. Between the TNT palm and the thumb domain is an ~15-Å-deep crevice occupied by two IFT β-turns, named TNT-interaction loops 1 and 2 (Figs. 3c and 4a), that penetrate deeply inside the TNT core and make extensive electrostatic contacts. Although the structure of IFT in complex with TNT superimposes well with the structure of free IFT 26 (r.m.s. deviation ~0.52 Å), the side chain conformations in the TNT-interaction loops (N36, K37 and E40; D58, R59, M60 and S61) projecting inside the TNT crevice are different ( Fig. 3c ).
Identification of putative NAD + -binding site of TNT
TNT has no sequence similarity to any protein of known function 13 , and an exhaustive search for similar structures failed to yield significant hits. However, a restraint-based structural alignment of TNT with the SPN glycohydrolase domain 27 and the ribosyltransferase domains of the diphtheria and cholera toxins 28,29 revealed a similar basic architecture of the NAD + -binding core. Noticeable differences are that the TNT core contains only six β-strands as opposed to the seven found in all known NAD + -using toxins, and it is substantially smaller, with only two short α-helices and two 3 10 helices. In silico docking readily placed NAD + in the deep crevice of TNT ( Supplementary Fig. 4a ) with a predicted free energy of binding of −8.7 kcal/mol. All solutions share a similar position of the nicotinamide group, which inserts deeply inside the TNT crevice. Inspection of the amino acids surrounding the putative NAD + -binding pocket identified Q822, Y765 and R757 as residues possibly involved in NAD + binding and hydrolysis ( Supplementary Fig. 4b ), on the basis of similar positions of catalytic amino acids of ADP-ribosylating toxins 30 .
Out of these residues, Q822 is highly conserved among TNT homologs. To determine the role of Q822 in NAD + hydrolysis, we produced the TNT Q822A protein in E. coli in the presence of the antitoxin IFT to prevent secondary mutations and separated the complex by selective thermal denaturation (as shown for wild-type TNT in Supplementary Fig. 2c ). Purified TNT Q822A maintained structural integrity, as determined by IFT binding ( Supplementary  Fig. 5a ), but its NAD + glycohydrolase activity was decreased by two-fold npg a r t i c l e s compared to that of wild-type TNT (Fig. 4c) ; these results suggest that Q822 is important, but not essential, for binding and/or hydrolysis of NAD + . Similarly, the TNT Y765A mutant protein also had decreased NAD + glycohydrolase activity in vitro ( Fig. 4c) and decreased cytotoxicity in macrophages ( Fig. 4d) . By contrast, previous studies have shown that mutation of the corresponding Q148 and Y65 residues in diphtheria toxin resulted in the drastic loss of its ADP-ribosyltransferase and NAD + glycohydrolase activities 31, 32 , suggesting that TNT uses a different mechanism of NAD + binding and possibly hydrolysis. The highly conserved G818 residue also lines the putative NAD +binding pocket of TNT ( Fig. 4b) . However, the purified TNT G818V protein was unfolded, as indicated by circular dichroism and lack of IFT binding (not shown), and hence did not hydrolyze NAD + (Fig. 4c) . Because several single mutants including TNT Q822A did not completely eliminate the NAD + glycohydrolase activity of TNT, except for the unfolded TNT Q818V mutant ( Fig. 4c) , we exploited the inadvertent selection of an additional mutation, H792N, in E. coli carrying a TNT Q822K expression vector in the absence of IFT. Indeed, the purified TNT H792N Q822K protein had no detectable NAD + glycohydrolase activity in a sensitive assay with a detection limit of 0.1 µM NAD + (Fig. 4c ) but efficiently bound to IFT in pulldown experiments ( Supplementary Fig. 5b) , thus demonstrating that the loss of NAD + glycohydrolase activity was not caused by impaired protein folding. When taken together, this mutational analysis identifies the putative NAD + -binding site of TNT but also reveals substantial differences compared to SPN and ADP-ribosylating toxins 30 .
TNT-mediated NAD + depletion causes macrophage cell death
To assess whether NAD + depletion by TNT leads to cell death, we transiently transfected RAW 264.7 macrophages with plasmids for expression of EGFP fusions with wild-type or mutant TNT. Thereafter, we assessed macrophage viability by 7-amino-actinomycin D (7AAD) staining and flow cytometry. Whereas wild-type TNT killed more than 50% of the transfected macrophages, the noncatalytic TNT H792N Q822K mutant completely lost toxicity, as did the unfolded TNT G818V mutant (Fig. 4d) ; these results indicate that macrophage cell death is indeed dependent on the NAD + glycohydrolase activity of TNT. The TNT Q822A mutant showed intermediate cytotoxicity ( Fig. 4d) , which is consistent with its partial enzymatic activity ( Fig. 4c) . Expression of all TNT mutants was much higher than that of wild-type TNT, as shown by fluorescence of the GFP-fusion proteins (not shown), thus demonstrating that the lower toxicity was not due to lower expression levels.
To examine the role of the NAD + glycohydrolase activity of TNT in the context of Mtb infection, we infected THP-1 macrophages with wild-type Mtb, the ∆cpnT mutant and the ∆cpnT mutant complemented with cpnT encoding the wild-type TNT domain or the noncatalytic TNT H792N Q822K mutant. Macrophages infected with wild-type Mtb showed a drastic decline in NAD + levels 24 h after infection, in contrast to macrophages infected with the Mtb ∆cpnT deletion mutant, in which NAD + levels remained high ( Fig. 4e) . Importantly, the noncatalytic TNT H792N Q822K mutant was expressed to similar levels as wild-type TNT and showed a similar subcellular localization pattern ( Fig. 5) , but it did not decrease NAD + levels beyond those of the Mtb ∆cpnT deletion mutant ( Fig. 4e) . This result is consistent with the complete loss of NAD + glycohydrolase activity of the TNT H792N Q822K mutant (Fig. 4c) , and it demonstrates that NAD + depletion in macrophages infected with Mtb mainly depends on the enzymatic activity of TNT. It should be noted that NAD + levels are also decreased by 40% in Mtb-infected macrophages compared to uninfected macrophages, through TNT-independent mechanisms (Fig. 4e) .
To correlate the observed TNT-dependent NAD + depletion during infection with the known cytotoxicity of Mtb 7 , we measured the viability of macrophages infected with Mtb strains secreting wildtype TNT or the catalytically inactive TNT H792N Q822K . Importantly, the cytotoxicity of Mtb secreting the noncatalytic TNT H792N Q822K was decreased to the same level as that of the Mtb cpnT-deletion mutant (Fig. 4f) . The interpretation of the infection experiments is complicated by the attenuation of the Mtb cpnT-deletion mutant in macrophages 13 because the decreased bacillary load may also decrease cytotoxicity by mechanisms other than NAD + hydrolysis. However, the bacterial load of the Mtb strain expressing only the N-terminal domain of CpnT was increased by 12-fold but resulted in the same cytotoxicity as the cpnT mutant, thus indicating that the observed difference in cytotoxicity is probably not a consequence of fewer bacteria but is dependent on TNT activity 13 . Furthermore, these results link NAD + depletion to cytotoxicity and are also consistent npg a r t i c l e s with our observations that no NAD + is detectable in Jurkat T cells 24 h after induction of tnt expression (Supplementary Fig. 1b ) and that more than 90% of these cells died during this time 13 . Supplementation of this Jurkat T-cell line with nicotinamide or nicotinic acid, both NAD + precursors that elevate intracellular NAD + levels ( Supplementary Fig. 6a and refs. 18,33) , decreased TNT-induced toxicity (Supplementary Fig. 6c ). This effect is not due to inhibition of the enzymatic activity of TNT caused by addition of nicotinamide or nicotinic acid (Supplementary Fig. 6b) . These NAD + -precursor supplementation experiments support the direct role of NAD + hydrolysis in the toxicity of TNT. When taken together, these experiments provide evidence that NAD + hydrolysis by TNT is the main toxicity mechanism of Mtb in macrophages.
TNT gains access to the macrophage cytoplasm
Uptake of many bacterial toxins into target cells occurs by receptormediated endocytosis [34] [35] [36] . To examine putative cellular uptake pathways for TNT, we added purified TNT protein to THP-1 macrophages. However, extracellular TNT toxin did not induce macrophage cell death (Supplementary Fig. 7a) , a result indicating that TNT lacks a membrane translocation domain. Hence, secreted TNT needs to exit the Mtb-containing phagosome in order to gain access to the NAD + pools in the macrophage cytosol and to induce necrotic cell death of infected macrophages, as we proposed previously 13 . Furthermore, internalized latex beads coated with purified TNT protein did not cause macrophage death, in spite of their glycohydrolase activity in vitro (Supplementary Fig. 7b,c) , thus suggesting that TNT itself is not capable of phagosomal exit. To examine the cellular localization of TNT, we selectively permeabilized the plasma membrane but not the phagosomal membrane with digitonin to visualize proteins within the cytosol of macrophages infected with Mtb 37 . To validate this method, we stained Mtb-infected macrophages with an antibody to the antigen 85 complex (Ag85), a major secreted protein complex of Mtb 38 . Ag85 was detectable only when macrophage membranes were solubilized by Triton X-100 but not in the presence of digitonin alone (Fig. 5) , thus indicating that the phagosomal membrane is not permeabilized by digitonin. We then showed that TNT is secreted by Mtb into the cytosol of infected macrophages while the bacteria are still confined to the phagosome (Fig. 5a,b) . The fraction of macrophages with cytosolic localization of TNT 48 h after infection was ~50%, 0% and 10% for wild-type Mtb, Mtb ∆cpnT and Mtb ∆ESX-1, respectively. Interestingly, TNT is not evenly distributed in the cytosol of macrophages but instead shows punctate localization, possibly from association with cellular vesicles and/or organelles. We observed a similar phenotype for the catalytically inactive TNT H792N Q822K mutant (Fig. 5a,b) , results indicating that the punctate distribution of TNT in macrophages is not associated with its enzymatic activity. Access to the macrophage cytosol, but not secretion of TNT by Mtb, completely depends on the ESX-1 secretion system (Fig. 5a,b) , consistently with previous findings that the phagosomal membrane is perforated in an ESX-1-dependent manner 39 and that the ESX-1 system is required for Mtb cytotoxicity 7 .
Direct injection of TNT protein kills zebrafish zygotes
Zebrafish zygotes are a well-established model to study higher-order vertebrates. Fundamental cellular processes are highly conserved in zebrafish, and the short 24-h developmental period from singlecelled zygote to embryo enables rapid phenotype detection 40 . Further, defined quantities of protein and protein complexes such as TNT-IFT can be easily injected directly into the cytoplasm to eliminate Figure 6 TNT is toxic in zebrafish. Zebrafish zygotes were injected at the one-or two-cell stage with 80 pg of purified BSA, wild-type TNT or the noncatalytic TNT H792N Q822K mutant, or with 160 pg of purified TNT-IFT complex. Representative images from two separate experiments are shown for embryos at 1.5 and 24 h after injection (h.p.i.). Survival was determined by the presence of a heartbeat. Scale bar, 0.5 mm. Quantification of zebrafish zygote survival is shown in Supplementary Table 2 . npg a r t i c l e s potential confounding factors of transfection and infection experiments such as varying gene expression, potentially altered properties of GFP-fusion proteins and cosecretion of other proteins and/or lipids. To examine the toxicity of purified TNT protein in vivo, we injected zebrafish zygotes with buffer, BSA, wild-type TNT, catalytically inactive TNT H792N Q822K or wild-type TNT-IFT-complex proteins at the one-or two-cell stage. Whereas zygotes injected with buffer and BSA developed into morphologically normal larvae with heartbeats 24 h after injection, injection of wild-type TNT dramatically compromised embryonic development (Fig. 6) . This result demonstrated that the TNT protein itself is toxic when directly introduced into the host-cell cytosol. In contrast, injection of the noncatalytic TNT H792N Q822K mutant was not lethal to embryonic development; hence, NAD + hydrolysis is required for TNT toxicity ( Fig. 6 and Supplementary  Table 2 ). The TNT-IFT complex was not toxic when injected into zebrafish zygotes (Supplementary Table 2) , thus indicating that this protein complex is not dissociated under physiological conditions. Furthermore, TNT protein injected in the tail veins of zebrafish larvae 24 h after fertilization was not toxic (data not shown), in contrast to cholera toxin 41 . These results indicate that TNT lacks a cellular signal to access the host-cell cytoplasm, unlike the cholera toxin, which contains a cell receptor-binding subunit 42 . Together, the results of the zebrafish protein-injection experiments are consistent with those of the macrophage transfection ( Fig. 4d) and infection experiments (Fig. 4e,f) , and they show that TNT's toxicity in eukaryotic cells is completely dependent on its cytosolic localization and NAD + glycohydrolase activity.
DISCUSSION
The control of host-cell death is of utmost importance for the survival, escape and dissemination of M. tuberculosis. It has been clearly shown that Mtb induces a necrotic-like cell death 7 , but the molecular mechanism of this process was unclear 43 . Our recent discovery of TNT as a new Mtb toxin led us to hypothesize that TNT is secreted by Mtb to induce cell death of infected macrophages 13 . In this study, we found that TNT (i) hydrolyzes the essential cellular cofactor NAD + in vitro, (ii) translocates to the macrophage cytosol in an ESX-1dependent manner, while Mtb is still trapped in phagosomes; and (iii) kills macrophages infected with Mtb by depleting NAD + . Nonetheless, it remains unclear whether TNT-induced cell death results directly from metabolic collapse after NAD + depletion, from other molecular events triggered by low NAD + levels or from a combination of different mechanisms. For example, low NAD + levels have been shown to impair glycolysis, thereby preventing cells from rapidly generating ATP. Metabolic collapse leading to necrotic cell death can be prevented by NAD + replenishment 16, 17, 44, 45 , as also shown for TNT in this study (Supplementary Fig. 6 ). However, depletion of cytoplasmic NAD + also deprives the cell from pyruvate, thus blocking the tricarboxylic acid cycle in mitochondria 46 . Mitochondrial dysfunction is known to increase production of reactive oxygen species and to activate calcium-dependent proteases (calpains) that disrupt the cytoskeletal network 47 . Moreover, reactive oxygen species and calpains permeabilize lysosomes and thereby release lipases, which degrade phospholipids and disrupt mitochondrial and cellular membranes, as observed during Mtb infection of macrophages 7 . Further, the observation that a TNT-deletion mutant has a residual cytotoxicity of about 20-30% compared to that of wild-type Mtb in macrophage infection experiments (Fig. 4f) indicates the involvement of other factors in Mtb-mediated cell death. These factors may include the ESX-1 substrate ESAT-6, which damages lipid membranes 6 . In addition, Mtb activates the cytosolic 'danger' sensor NLRP3 in an ESAT-6-dependent manner, thus initiating inflammasome formation 48 and impairing the membrane-repair machinery through the action of lipoxin A 4 , which downregulates the proapoptotic and necrosis-protecting prostaglandin E2 (refs. 4,5) .
In all, this study shows that Mtb-induced necrosis of infected macrophages is mainly dependent on NAD + hydrolysis by TNT, although the exact sequence of the downstream events that lead to cell death remains to be elucidated.
Because necrosis of infected cells promotes bacterial dissemination, the utilization of TNT's NAD + glycohydrolase activity is highly advantageous for Mtb, in contrast to the use of ADP-ribosylating toxins by other bacterial pathogens to trigger apoptosis [49] [50] [51] . TNT may also enable Mtb to control the timing and mode of cell death in other cell types such as neutrophils and dendritic cells, which Mtb is known to invade 52, 53 . However, the toxicity of TNT is also detrimental to Mtb 13 . To protect itself from self-poisoning, Mtb produces the immunity factor IFT (Fig. 2) . The atomic structure of the TNT-IFT complex presented in this study reveals a fully electrostatic binding interface, which ensures picomolar binding affinity between these two proteins and may enable dissociation of TNT-IFT at acidic pH. TNT has similar catalytic activity as the SPN glycohydrolase of group A streptococci 54 and a similar protective mechanism 23 , although TNT and IFT lack identifiable sequence and structural similarities with proteins of known function. Although functionally equivalent, TNT and SPN differ in at least three ways. First, TNT is markedly smaller (~150 versus 450 residues), and it represents one of the smallest NAD + -binding domains identified to date. Second, TNT has ~160-fold-slower catalytic turnover of NAD + but similar substrate affinity (Supplementary Table 1) , possibly resulting in slower toxicity kinetics in vivo. Finally, the secretion mechanisms of TNT and SPN differ greatly. Although a signal peptide is sufficient to enable SPN secretion across the membrane of S. pyogenes, TNT constitutes the C-terminal domain of the outer-membrane protein CpnT, which resembles autotransporters of Gram-negative bacteria 13 . In the Pfam database, TNT is annotated as a member of the domain of unknown function 4237, which comprises over 600 homologs encompassing approximately 300 bacterial and fungal species 55 . Thus, our results identify a class of new toxins present in a large group of microorganisms including many mycobacteria, Listeria monocytogenes and Yersinia pestis, which are known to induce necrosis of infected host cells 56, 57 . In conclusion, our study revealed the structure and enzymatic activity of TNT as an NAD + glycohydrolase that affects hostcell fate on multiple levels. These findings have broad implications in microbial pathogenesis.
METHODS
Methods and any associated references are available in the online version of the paper.
Accession codes. Coordinates and structure factors for TNF-IFT have been deposited in the Protein Data Bank under accession code 4QLP.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper.
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ONLINE METHODS
Bacterial strains and reagents. E. coli strains DH5α or DH5αZ1 and BL21(DE3) were used for cloning and expression experiments, respectively, and were routinely grown in Luria-Bertani broth at 37 °C. The M. tuberculosis H37Rv derivative avirulent strains mc 2 6206 or mc 2 6230 were grown in Middlebrook 7H9 medium (Difco) supplemented with 0.2% glycerol, 0.02% tyloxapol and 10% OADC (Remel) or on Middlebrook 7H10 plates supplemented with 0.5% glycerol and 10% OADC (Remel). All bacteria strains used are shown in Supplementary  Table 3 . Growth media of the auxotrophic M. tuberculosis strains were supplemented with 24 µg/ml pantothenate and 50 µg/ml l-leucine. Hygromycin B was purchased from Calbiochem. All other chemicals were purchased from Merck or Sigma at the highest purity available. Enzymes for DNA restriction and modification were from New England BioLabs and Invitrogen. Oligonucleotides were obtained from IDT. β-NAD + and doxycycline were purchased from Sigma. Antibiotics were used when required at the following concentrations: hygromycin (200 µg/ml for E. coli; 50 µg/ml for mycobacteria), kanamycin (30 µg/ml), carbenicillin (100 µg/ml) and chloramphenicol (25 µg/ml). Live/Dead Fixable Green Cell Stain was purchased from Invitrogen. Polyclonal rabbit anti-TNT antibody was generated previously 58 . Monoclonal Anti-Ag85 complex (clone IT-44 (HBT7)) was obtained from BEI Resources (NR-13826). Validation results are provided on the manufacturers' websites.
Plasmid construction. Construction of plasmids are described in a flowchart that includes the oligonucleotide pairs ( Supplementary Table 4 ) used for PCR amplification and restriction enzymes used for cloning ( Supplementary Fig. 8 ).
All plasmids used are shown in Supplementary Table 5 .
Purification of the TNT-IFT complex. E. coli BL21(DE3) cells containing both plasmids pML1995 and pML1999 were grown in 2 l of the autoinduction liquid medium ZYP-5052 (ref. 59) supplemented with 100 µg/mL carbenicillin and 25 µg/mL chloramphenicol until the culture reached saturation (OD 600 ~10) for 3 h. The cells were harvested by centrifugation (7,000g, 4 °C, 20 min) and washed with a buffer containing 20 mM Tris, pH 7.6, and 200 mM NaCl. The cell pellet (24 g) was resuspended with 130 mL of the same buffer supplemented with 100 µg/mL lysozyme, 1 mM PMSF, 1 mM EDTA and 2.5 units benzonase per milliliter of suspension and was subjected to lysis with a French press (five cycles at 1,000, 5,000, 10,000 and 15,000 p.s.i. each). The resulting lysate was cleared by centrifugation (60,000g, 4 °C, 45 min). The complex MBP-TNT-IFT was first purified with Ni-NTA affinity, and then the elution was further purified with amylose resin, both according to manufacturers' protocols. The protein concentration of the fusion complex was determined with the Bradford assay, and the corresponding amount of TEV protease NIa and 1 mM TCEP was added. The digestion was performed at 4 °C and was followed by SDS-PAGE analysis over a period of 96 h when >90% of the fusion protein was cleaved. The resulting protein mixture was passed through a Talon-Co column to retain MBP, the uncleaved fusion protein and the NIa protease, and the complex TNT-IFT was recovered in the flow through. The fractions containing the toxin-immunity factor complex were pooled, concentrated by ultrafiltration with an Amicon Ultracel unit (3-kDa cutoff) and subjected to size-exclusion chromatography with a Superdex 75 pg 16/60 column, washed with 20 mM Tris, pH 7.6, and 300 mM NaCl at a 1 mL/min flow rate and kept at 15 °C. Absorbance at 280 nm was recorded on a paper chart, and the chromatograms were digitized with a scanner and then converted with XYscan (http://rhig.physics.yale.edu/~ullrich/xyscanDistributionPage/). The column was calibrated with albumin from bovine serum (66 kDa), carbonic anhydrase from bovine erythrocytes (29 kDa) and cytochrome C from horse heart (12.4 kDa) . The fractions containing the TNT-IFT complex were pooled together, and the concentration was measured with the Bradford assay.
Crystallization of the TNT-IFT complex and structure determination. Crystals of the TNT-IFT complex were obtained with the hanging-drop vapor-diffusion method by mixing 2 µl of TNT-IFT complex at 25 mg/ml with 2 µl of 0.2 M ammonium formate and 24% (w/v) PEG 3350, pH 6.2, and the resultant drop was equilibrated against 600 µl of crystallization solution, at 18 °C. Diffraction-quality, large rod-like crystals grew in 2-7 d to exceed ~1 mm in length. Crystals were harvested in nylon cryo-loops, cryoprotected by quick passage through a solution containing mother liquor solution supplemented with 27% ethylene glycol and flash-frozen in liquid nitrogen. Diffraction data were collected at beamlines X6A and X29 at the National Synchrotron Light Source (NSLS) on an ADSC Quantum Q270 and a Quantum-315r CCD detector, respectively. Data indexing, integration and scaling were carried out with the HKL2000 package 60 (Table 1) . Initial phases were obtained by molecular replacement with Phaser 61 with the deposited structure of Rv3902c (PDB 4O6G) as a search model and diffraction intensities from crystal form 2, which extends to 1.9-Å resolution ( Table 1 ). An initial solution, which accounts for only ~40% of atoms in the asymmetric unit, was rebuilt automatically with Buccaneer 62 and phenix.autobuild 63 and manually with Coot 64 , and was refined with phenix.refine 63 , to yield an initial complete model of the TNT-IFT complex. This model was then replaced in the high-resolution crystal form I ( Table 1 ) and refined to 1.10-Å resolution with phenix.refine 63 . The final model includes residues 1-175 of IFT, residues 648-846 of TNT, riding hydrogens and 684 water molecules; R free was calculated with 2,000 randomly selected reflections; the Ramachandran plot shows over 95% of residues in the most favored regions and no disallowed residues, as assessed by MolProbity 65 . The structure was analyzed with the PISA server 66 and PDBsum 67 , and all structural illustrations in the paper were done with PyMOL (http://www.pymol.org/). Docking studies. Docking of NAD + inside the refined structure of TNT (stripped of IFT) was performed with AutoDock Vina 68 . Atomic coordinates for NAD + were downloaded from Coot 64 and idealized with phenix.elbow 69 . Only polar hydrogens in TNT were used for docking simulation. To define an appropriate search space to dock NAD + onto TNT, a generous grid box of 44 × 32 × 26 Å 3 (along x, y and z) was generated around the TNT crevice. Ten solutions were generated by Vina with calculated free binding energies (∆G B ) between −8.6 and −7.7 kcal/mol (Supplementary Fig. 6 ). All solutions share a similar position of the nicotinamide group that inserts deeply inside the TNT crevice, thus placing the hydrolyzable bond between nicotinamide and ribose in proximity to Gln822 and Tyr765. In contrast, the position of the NAD + adenosine-dinucleotide group varies greatly among different solutions as a result of the greater degree of freedom of this group inside TNT. The phosphate at position β is always positioned close (~4 Å) to Arg757. TLC assays. NAD + glycohydrolase assays were performed by incubation of TNT (20 nM) with 1 mM NAD + for 30 min at 37 °C. 2 µL of this reaction was spotted onto silica-gel glass TLC plates (Sigma). The same amounts of standard molecules NAD, ADP-R and cADP-R were spotted. The TLC was developed in the ascending direction for 20 min at room temperature with a mixture of 30% water, 70% ethanol and 0.2 M ammonium bicarbonate. After being dried, the TLC plates were sprayed uniformly with 10% cupric sulfate in 8% aqueous phosphoric acid, allowed to dry and then placed into a 145 °C oven for 10-20 min.
Enzyme kinetics of TNT. Hydrolysis of β-NAD + by TNT was monitored by detection of fluorescence as previously described 71 , with minor modifications. Briefly, initial rates of hydrolysis were measured by incubation of various concentrations of NAD + (50 µM to 1.6 mM) with 10 nM TNT in assay buffer (20 mM Tris, pH 7.4, and 200 mM NaCl) at 37 °C. 100-µL aliquots of the reaction were taken at various time points (1-10 min) and quenched by the addition of 70 µL of 5 M NaOH in a 96-well plate. The plate was then incubated at room temperature for 1 h in the dark to develop the alkaline treatment-generated fluorescence signal of NAD. Subsequently, the relative fluorescence at 360/460 nm (excitation/emission filter set) was determined on a BioTek Synergy HT plate reader and compared to a standard NAD + concentration curve. The initial rate of NAD + hydrolysis was determined by linear regression of plots of substrate depletion versus time. Thereafter, the rate was plotted as a function of NAD + concentration and was fit with the Michaelis-Menten equation to determine the K m , V max and k cat for the enzyme. Nonlinear regression analysis was performed with SigmaPlot 11.
Purification of IFT for surface plasmon resonance experiments. E. coli BL21(DE3) cells containing pML1974 were grown in liquid LB medium supplemented with 100 µg/mL carbenicillin to an OD 600 of 0.8. The culture was then induced with 1 mM IPTG for 3 h at 37 °C. The bacterial pellet was resuspended in 20 mM Tris, pH 7.4, and 200 mM NaCl (5 mL/g cells) supplemented with 1 mg/mL lysozyme, 1 mM PMSF and 2.5 units benzonase per milliliter of suspension. The lysate was centrifuged at 10,000g, 4 °C for 45 min to obtain the soluble fraction. Purification of polyhistidine-tagged MBP-IFT from this fraction was completed with Talon-Co affinity chromatography according to the manufacturer's protocol. The eluted fractions containing the MBP-IFT fusion protein were pooled and dialyzed against 20 mM Tris, pH 7.4, and 200 mM NaCl to decrease the imidazole concentration before the addition of TEV protease NIa and 1 mM TCEP. The digestion was performed at 4 °C over a period of 72 h and was followed by SDS-PAGE analysis until >90% of the fusion protein was cleaved. The resulting protein mixture was passed through amylose resin to retain MBP and the uncleaved fusion protein, and the IFT was recovered in the flow through. IFT was further purified by anion exchange (Hi-Trap Q FF) in 20 mM Tris, pH 8, with a 10-500 mM NaCl gradient.
Surface plasmon resonance binding assays and kinetic analysis.
Binding interactions between TNT and IFT were examined with a Biacore T200 molecularinteraction analysis system (GE Healthcare). HBS-EP (0.01 M HEPES, 150 mM NaCl, 3 mM EDTA and 0.005% polysorbate 20, pH 7.4) was used as the running buffer for the immobilization and kinetic studies. A Series S Sensor Chip NTA (Biacore) was used to immobilize polyhistidine-tagged MBP-TNT (160 nM) onto its flow cell at a flow rate of 5 µl/min for 120 s to reach a ligand density of approximately 500 RU. A control reference flow cell was used when the Ni-loading step onto the NTA chip was omitted before ligand capture, but the protocol otherwise contained all the same steps as for the active flow cell. Different concentrations of the analyte IFT (0-62.5 nM) were diluted in running buffer, and injection was carried out for 60 s at a flow rate of 20 µL/min to observe association, and then dissociation was allowed to proceed for 10 min. A constant temperature of 25 °C was used throughout the entire kinetic study. In order to minimize nonspecific binding and instrumental drift on the generated binding sensorgrams, a double referencing of the data was performed. The binding responses over the reference flow cell were subtracted from the active surface to correct for nonspecific binding. Furthermore, an analyte run with running buffer alone was also subtracted from the binding sensorgrams to minimize noise. Biacore evaluation software was used to analyze the binding kinetics. A 1:1 binding model was used to fit the binding response curves over five analyte concentrations, thus resulting in residuals well within quality-control standards, as indicated by the chi-squared value of 0.183.
In vitro pulldown assay. Purified recombinant TNT (5 µg) was incubated with equimolar amounts of MBP-IFT overnight at 4 °C with 25 µL packed amylose resin (NEB) in a final volume of 75 µL reaction buffer (20 mM Tris and 200 mM NaCl, pH 7.4). Equivalent amounts of TNT and MBP-IFT were incubated independently with amylose resin as controls. After incubation, the resin was washed thoroughly with reaction buffer. The washed resin was combined with an equivalent volume of protein-loading buffer and was heated at 95 °C for 10 min to dissociate resin-bound protein. Captured proteins were analyzed by SDS-PAGE stained with Coomassie blue.
Cell culture, transfection and flow cytometry. Human THP-1 monocytic cell line (ATCC TIB-202) and mouse RAW 264.7 macrophage cell line (ATCC TIB-71) were propagated in RPMI-1640 or Dulbecco's modified Eagle's medium (DMEM), respectively, supplemented with 10% FBS, 10 mM HEPES, 2 mM l-glutamine (Thermo), 100 IU/mL penicillin and 100 µg/mL streptomycin. Jurkat-derived cell lines 58 were maintained in RPMI-1640 medium supplemented with the same reagents. All cells were grown in a 37 °C humidified incubator at 5% CO 2 . Cell lines routinely tested negative for mycoplasma contamination, as tested every month. For transfections, 5 × 10 5 RAW macrophages were allowed to adhere onto glass coverslips in 24-well plates overnight. Transfection was achieved with FuGENE HD (Promega). In brief, 0.5 µg of purified plasmid DNA (pML3035, pML3036 and pML3059) was mixed with 1 µL of FuGENE reagent in a final volume of 50 µL with DMEM. This mixture was incubated at room temperature for 15 min and then was added to the macrophages contained in 450 µL of medium. Thirty hours after transfection, cells were washed and detached by trypsin-EDTA. Cells were harvested by low-speed centrifugation and resuspended in PBS containing 1% FBS, and stained with 7-amino-actinomycin D (7AAD, eBioscience) according to the manufacturer's recommendation. Analysis of cell viability was quantified by flow cytometry with the Guava easyCyte. Positively transfected cells were gated according to green fluorescence (FL-1; GFP), and the percentage of nonviable cells out of the transfected population was gated according to red fluorescence (FL-2; 7AAD). NAD + content in macrophages infected with Mtb. THP-1 monocytes were differentiated with 100 ng/mL PMA for 24 h and were subsequently infected with Mtb strains at an MOI of 20:1. 24 h after infection, macrophages were lysed in 0.025% SDS to release all NAD + from the macrophages but not mycobacteria. The EnzyFluo NAD/NADH kit was then used to quantify the amount of NAD + in each sample. Intracellular staining. Mtb-infected RAW 264.7 macrophages on glass coverslips were fixed with 4% paraformaldehyde for 1 h at room temperature and were subsequently washed multiple times with PBS before staining. Cells were selectively permeabilized as previously described 72 . In brief, cells were permeabilized with 25 µg/mL digitonin in PBS alone for 5 min or in combination with 0.2% Triton-X100 in PBS for an additional 5 min. Then cells were washed and blocked with PBS containing 1% BSA (S buffer) for 20 min. Thereafter, polyclonal anti-TNT antibody (1:75) or monoclonal anti-Ag85 antibody (1:50) was used in S buffer and was incubated with the cells for 60 min. After three washes with PBS, secondary anti-rabbit or anti-mouse Alexa Fluor 555 (Invitrogen) was used at a dilution of 1:1,000 and was incubated with the cells for 30 min. Cells were then washed three times with PBS, and coverslips were mounted onto microscope slides with FluorSave (Calbiochem) for fluorescence imaging. Imaging was performed with an Axiovert 200 microscope (Carl Zeiss) equipped with a 100×/1.4 Plan-Apochromat (Carl Zeiss). Images were recorded with an AxioCam MRc camera (Zeiss) coupled to Axiovision v4.5 software (Carl Zeiss).
TNT toxicity in Jurkat cells and rescue by nicotinamide. Jurkat cells expressing tnt under an inducible system 58 were pretreated with 5 mM nicotinamide, 10 µM nicotinic acid or both in combination for 2 h. At that point, expression of tnt was induced by addition of 100 ng/mL doxycycline for 2 h. Cells were subsequently washed free of doxycycline and were incubated in regular medium for 24 h. Cell viability was then assessed with the 7AAD dye and flow cytometry.
Additional methodology. RNA profiling experiments, thermal stability measurements and zebrafish injection assays are described in Supplementary Note. 
